Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-150
Closed -$13.5K 181
2025
Q1
$13.5K Hold
150
0.01% 189
2024
Q4
$14.9K Hold
150
0.01% 180
2024
Q3
$17K Hold
150
0.01% 170
2024
Q2
$18.6K Hold
150
0.01% 161
2024
Q1
$19.8K Hold
150
0.01% 158
2023
Q4
$16.4K Hold
150
0.01% 167
2023
Q3
$15.4K Hold
150
0.02% 141
2023
Q2
$17.3K Hold
150
0.02% 115
2023
Q1
$16K Hold
150
0.03% 96
2022
Q4
$16.6K Hold
150
0.03% 93
2022
Q3
$13K Hold
150
0.13% 95
2022
Q2
$14K Hold
150
0.12% 94
2022
Q1
$12K Hold
150
0.01% 119
2021
Q4
$11K Buy
+150
New +$11.9K 0.01% 127

Other funds holding MRK

FSC Wealth Advisors's MRK Position: Q2 2025 in Review

FSC Wealth Advisors sold out of Merck (MRK) in Q2 2025, closing a stake of 150 shares — an estimated $13.5K sold.

FSC Wealth Advisors first reported a position in MRK in Q4 2021 and held it in 14 quarters. The position peaked at $19.8K in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • FSC Wealth Advisors reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • FSC Wealth Advisors sold 150 Merck shares in Q2 2025, an estimated $13.5K.
  • FSC Wealth Advisors first reported a position in Merck in Q4 2021 and held it in 14 quarters.
  • FSC Wealth Advisors's Merck position peaked at $19.8K in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on FSC Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.